In a recent study using a murine Arf−/−Bcr-Abl1 mouse model, BCR::ABL1-specific CD4+ memory T cells played a protective role, with T cell depletion drastically increasing leukemia outgrowth after dasatinib or cytotoxic chemotherapy (59). This evidence concerns the gene BCR and leukemia.